Compare Compass Inc. Class A Common Stock (COMP) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| COMP | IBRX | |
|---|---|---|
Market Cap | $7.05B | $10.33B |
Volume | 15,310,192 | 11,745,198 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $11.55 |
52-Week Low | $6.68 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $10.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
